Author

James Anderson

Observed names: J Anderson, JAMES E.M. ANDERSON, James ANDERSON, James E M Anderson, James E.M. Anderson

Institution: University of Nebraska Medical Center

Observed institutions: Nebraska Medical Center, Harvard University, Royal Perth Hospital, University of Nebraska Medical Center

OpenAlex ID: A5111665592

Randomised phase 2 trial of SIR‐Spheres® plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer

2004 · Guy Van Hazel, Anthony Blackwell, et al. · Journal of Surgical Oncology · 442

An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.

1999 · R T Silver, S H Woolf, et al. · PubMed · 374

Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone

1987 · R. Derek T. Jenkin, Carl Boesel, et al. · Journal of neurosurgery · 150

Effect of selective internal radiation therapy and hepatic arterial chemotherapy on normal liver volume and spleen volume

2001 · Paul Moroz, James E.M. Anderson, et al. · Journal of Surgical Oncology · 33

Increased Cytotoxicity and Decreased In Vivo Toxicity of FdUMP[10] Relative to 5-FU

1999 · Jinqian Liu, Alan Skradis, et al. · Nucleosides and Nucleotides · 26

Phase II trial of ifosfamide and mesna in previously treated patients with non‐Hodgkin's lymphoma: Cancer and leukemia group B study 8552

1988 · Delvyn C. Case, James Anderson, et al. · Medical and Pediatric Oncology · 15

Web-based decision support for clinical trial eligibility determination in an international clinical trials network

2003 · Philip P Breitfeld, Fred Ullrich, et al. · Controlled Clinical Trials · 13

Consumption of reduced-energy/low-fat diet or constant-energy/high-fat diet during mezerein treatment inhibited mouse skin tumor promotion

1994 · Diane F.Birt, Jill C.Pelling, et al. · Carcinogenesis · 9

Hazards of transrectal biopsy of prostate

1995 · Peter D Hughes, James E M Anderson · The Medical Journal of Australia · 8

Progress in Colon Cancer -- Do Molecular Markers Matter?

1994 · Margaret Tempero, James Anderson · New England Journal of Medicine · 8

Conflict between Research Design and Minimization of Risks in Pediatric Research

2000 · Bruce Gordon, Ernest Prentice, et al. · IRB Ethics and Human Research · 6

Hazards of transrectal biopsy of prostate

1995 · Peter D Hughes, James E M Anderson · The Medical Journal of Australia · 5

Phase II trial of ifosfamide/mesna and mitoxantrone in previously treated patients with non‐Hodgkin's lymphoma: Cancer and leukemia group B study 8753

1992 · Delvyn C. Case, Maria Teresa Santarelli, et al. · Medical and Pediatric Oncology · 5

A pilot study of trimodality breast imaging surveillance in young women at high risk of breast cancer in Western Australia

2009 · Christobel M Saunders, Gudrun Peters, et al. · The Medical Journal of Australia · 4

PDF

Percutaneous vertebroplasty: a novel treatment for acute vertebral fractures

2001 · James E M Anderson · The Medical Journal of Australia · 4

Preoperative taxane‐based chemotherapy in a standardized protocol for locally advanced breast cancer

2012 · Arlene CHAN, Peter C WILLSHER, et al. · Asia-Pacific Journal of Clinical Oncology · 3

Dropout by Design: Advance Planning for Research Participant Noncompliance

2011 · Toby Schonfeld, James Anderson · The American Journal of Bioethics · 2

Computed Tomography–Guided Prostate Sampling and Fiducial Marker Insertion in Patients With Absent Rectums

2023 · Matthew Chau, Manmeet Saluja, et al. · Journal of Computer Assisted Tomography · 1

Risk factors and outcome of children and young adults with initially unresected nonrhabdomyosarcoma soft tissue sarcoma: An analysis from the International Soft Tissue Sarcoma Consortium

2026 · Aaron R. Weiss, James Anderson, et al. · Cancer

PDF

Mycobacterium mucogenicum in Stem Cell Transplant Recipients and in High-Risk Patients With Hematological Malignancies, 2008-2013.

2015 · Maheen Abidi, Nathan Ledeboer, et al. · Open Forum Infectious Diseases

Significant Expansion of Myeloid Derived Suppressor Cells in Patients with High- Risk Breast Cancer Treated with Dose Dense Adjuvant Chemotherapy

2008 · James E Talmadge, Elizabeth Reed, et al. · Blood

Impressions of AUA

1993 · Deirdre Bird, James Anderson

Venous Collaterals and Metastatic Disease Coexisting in the Retroperitoneum

1989 · JAMES E.M. ANDERSON, DAVID RANSOM, et al. · Australasian Radiology

800 a Therapeutic Trial of 10 Drugs Vs. 4 Drugs in Non-hodgkin's Lymphoma (nhl)

1981 · Robert Chilcote, Derek Jenkin, et al. · Pediatric Research

Works count: 24

Citation count: 1,108

H-index: 8

I10-index: 7